MedTrace Logo

Evaluation of SYSTANE Ultra Lubricant Eye Drops

NCT00702377 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 109

Last updated 2012-02-02

Study results available
· View outcomes & findings →

Summary

To evaluate the safety and efficacy of two artificial tears in dry eye patients.

Conditions

  • Dry Eye

Interventions

OTHER

SYSTANE Ultra

SYSTANE Ultra Lubricant Eye Drops 1 drop each eye 4 times daily for 42 days

OTHER

Optive

Optive Lubricant Eye Drops 1 drop each eye 4 times daily for 42 days

Sponsors & Collaborators

  • Alcon Research

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-06-30
Primary Completion
2008-09-30
Completion
2008-09-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00702377 on ClinicalTrials.gov